PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA; Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: ircisner@utmb.edu.\', \'Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0028-3908(21)00321-X10.1016/j.neuropharm.2021.108766
?:hasPublicationType
?:journal
  • Neuropharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34454912
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.043
?:rankingScore_hIndex
  • 146
?:title
  • Covid-19 interface with drug misuse and substance use disorders.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34454912>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34454912>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all